Plasma endothelin in cyclosporine A-treated renal transplant patients

By Grekas D.   Bamichas G.   Karamouzis M.   Bacharaki D.   Savidis N.   Tourkantonis A.  

Transplantation Proceedings, Vol. 31, Iss. 3, 1999-05 ,pp. : 1703-1705

Elsevier

Access to resources Recommend Favorite

Endothelin-1 plasma levels in cyclosporine-treated stable renal transplant patients

By Costa C.   Cauduro R.L.   Lhulier F.   Cabral R.D.   Garcia R.G.   Manfro R.C.  

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 487-488

Elsevier

Access to resources Recommend Favorite

Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus

By Latorre A.   Morales E.   Gonzalez E.   Herrero J.C.   Ortiz M.   Sierra P.   Dominguez-Gil B.   Torres A.   Munoz M.A.   Andres A.   Manzanares C.   Morales J.M.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 63-64

Elsevier

Access to resources Recommend Favorite

Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients

By Vela C.G.   Cristol J.P.   Descomps B.   Mourad G.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 398-398

Elsevier

Access to resources Recommend Favorite

Cholesterol reduction in cyclosporine-treated renal transplant patients: effect on platelet-derived growth factor levels and platelet activation

By Rigatto C.   Rush D.   Perry Y.   Walker S.   Bose R.   Bolli P.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2591-2592

Elsevier

Access to resources Recommend Favorite